Sofosbuvir is a nucleotide analog and direct-acting antiviral agent approved for the treatment of chronic hepatitis C infection. It functions as a prodrug, undergoing intracellular metabolism to form its… Read more










































![Chemical structure of [(2R,3R,4R,5R)-3-(Benzoyloxy)-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-yl]methyl Benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1199809-22-7-2R3R4R5R-3-Benzoyloxy-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-ylmethyl-Benzoate.png&w=3840&q=75)
![Chemical structure of [(2R,3R,4R,5R)-3-(Benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl]methyl Benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1199809-23-8-2R3R4R5R-3-Benzoyloxy-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-ylmethyl-Benzoate.png&w=3840&q=75)
![Chemical structure of [(2R,3R,4R,5S)-3-(Benzoyloxy)-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-yl]methyl Benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1639301-16-8-2R3R4R5S-3-Benzoyloxy-4-fluoro-5-hydroxy-4-methyltetrahydrofuran-2-ylmethyl-Benzoate.png&w=3840&q=75)
![Chemical structure of [(2R,3R,4R,5S)-3-(Benzoyloxy)-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-yl]methyl Benzoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1500076-79-8-2R3R4R5S-3-Benzoyloxy-5-chloro-4-fluoro-4-methyltetrahydrofuran-2-ylmethyl-Benzoate.png&w=3840&q=75)




Sofosbuvir is a nucleotide analog and direct-acting antiviral agent approved for the treatment of chronic hepatitis C infection. It functions as a prodrug, undergoing intracellular metabolism to form its active triphosphate metabolite, which inhibits the NS5B RNA-dependent RNA polymerase to terminate viral replication. Laboratories working with this pharmaceutical agent rely on a comprehensive range of Sofosbuvir reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are essential for rigorous quality control, enabling accurate impurity profiling and the development or validation of stability-indicating analytical methods, such as RP-HPLC and LC-MS/MS. Furthermore, these related compounds support forced degradation studies and bioanalytical quantification, ensuring that pharmaceutical development meets stringent regulatory standards. The availability of high-quality, characterized standards facilitates precise monitoring of drug substance consistency and purity throughout the pharmaceutical lifecycle.